Testing supporting allergy diagnosis now accessible to more people in more communities

Thermo Fisher Scientific, the world leader in serving science, today announced it is making ImmunoCAP™ Specific IgE tests available to more patients across the U.S. The ImmunoCAP tests are now available to patients at all Kroger Health The Little Clinic LLC (“The Little Clinic”) locations, through a blood draw taken on site.

The ImmunoCAP specific IgE regional respiratory profiles now offered at The Little Clinic® require one blood draw that is analyzed at an offsite clinical laboratory. These tests are not new to the industry and are backed by 50+ years of research and development. This expansion into The Little Clinic sites will help enable more patients to take actionable preventative health steps to mitigate their allergies.

The Asthma and Allergy Foundation of America estimates that more than 100 million Americans experience various types of allergies each year, with allergies being the sixth leading cause of chronic illness in the U.S.¹ Identifying potential allergic triggers is an important component of managing patients presenting with upper and lower respiratory symptoms.

“Discovering the actual cause of allergy-like symptoms is vital to empowering patients to address their condition from a preventative medicine standpoint, allowing a more personalized management plan,” said Gary Falcetano, PA-C, AE-C, scientific affairs manager, Thermo Fisher Scientific. “Adding trusted and accurate ImmunoCAP testing to all The Little Clinic locations will enable clinicians to help many more patients get the answers they need to proactively manage their health.”

The Little Clinic’s onsite licensed health care professionals provide credible and convenient care to patients in a neighborhood grocery store. These clinicians can deliver personalized care through a variety of convenient, low-cost treatment, screening, and diagnostic services. Offering the ImmunoCAP blood test in local communities is one more service that makes healthcare accessible and convenient to patients.

Documented in more than 4,000 peer-reviewed publications and referenced in health guidelines around the globe, ImmunoCAP blood tests can help identify allergic sensitization to common environmental allergens – seasonal and perennial, indoor and outdoor.

ImmunoCAP specific IgE tests are the gold standard in in-vitro allergy diagnostics with hundreds of whole allergen, allergen mixes, and allergen component tests, which can be performed irrespective of a patient’s age, skin condition, medication, disease activity, and pregnancy.²ˉ⁴

Learn more about ImmunoCAP tests here: https://www.thermofisher.com/phadia/us/en/our-solutions/immunocap-allergy-solutions/specific-ige-single-allergens.html

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com

References

1.    Allergy Facts and Figures [Internet]. Asthma and Allergy Foundation of America [cited2023Apr3]. Available from https://aafa.org/allergies/allergy-facts/.

2.    Høst A, Halken S. Practical aspects of allergy-testing. Paediatr Respir Rev. 2003 Dec;4(4):312-8. PMID: 14629954.

3.    Siles, R.I. and F.H. Hsieh, Allergy blood testing: A practical guide for clinicians. Cleve Clin J Med, 2011. 78(9): p. 585-92.

4.    Pali-Schöll, Isabella et al. “Allergic diseases and asthma in pregnancy, a secondary publication.” The World Allergy Organization journal vol. 10,1 10. 2 Mar. 2017, doi:10.1186/s40413-017-0141-8 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333384/.